Phio Pharmaceuticals Shares Are Trading Higher After the Company Announced That Its Intratumoral Injection of Murine PH-762 Inhibited Tumor Growth in Murine Tumor Models and May Generate Memory-specific T Cells
Phio Pharmicals 宣布其瘤内注射小鼠 PH-762 可抑制小鼠肿瘤模型中肿瘤的生长并可能产生记忆特异性 T 细胞,此后 Phio Pharmicals 股价走高